Angus W. Thomson, PhD DSc DSc (Med) FAST trained in Immunology at the University of Birmingham (UK) and served as a faculty member at the University of Aberdeen School of Medicine before his relocation to the University of Pittsburgh where he currently a Distinguished Professor of Surgery, Professor of Immunology and Professor of Clinical & Translational Science in the Thomas E. Starzl Transplantation Institute. His principal research interests concern mechanisms underlying immune tolerance induction, regulatory immune cells, and cell therapy in transplantation. Dr. Thomson has received numerous National Institutes of Health grants (R-series, U-series and Program Project grants) and is currently Principal Investigator/Sponsor of first-in-human clinical trials of regulatory dendritic cells in liver and kidney transplantation. He is also Program Director of a NIH-funded University of Pittsburgh institutional research training grant in transplantation biology. He has served on and/or chaired study sections for the NIH, The American Heart Association and other foundations. He has served on the American Society of Transplantation’s Board of Directors and received the Society’s Established Investigator Award (Basic Science) and Mentoring Award. Dr Thomson has also received The Transplantation Society’s Distinguished Achievement Award (Basic Science) and the University of Pittsburgh Chancellor’s Distinguished Research Award and Provost’s Mentoring Award. He is an elected Fellow of the Royal Society of Edinburgh.